Adaptimmune Presents MAGE-A4 and MAGE-A10 pre-clinical data ... - GlobeNewswire (press release)

Adaptimmune Presents MAGE-A4 and MAGE-A10 pre-clinical data ...
GlobeNewswire (press release)
Preclinical testing raises no safety concerns for MAGE A4 - - Refined preclinical testing strategy expected to further mitigate risk of unexpected off-target toxicity -. PHILADELPHIA, Pa. and OXFORD, United Kingdom, April 16, 2018 (GLOBE NEWSWIRE ...e mais »